These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 20419430)

  • 1. Targeting drug transporters - combining in silico and in vitro approaches to predict in vivo.
    Bahadduri PM; Polli JE; Swaan PW; Ekins S
    Methods Mol Biol; 2010; 637():65-103. PubMed ID: 20419430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transporters as a determinant of drug clearance and tissue distribution.
    Shitara Y; Horie T; Sugiyama Y
    Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane transporters in drug development.
    Keogh JP
    Adv Pharmacol; 2012; 63():1-42. PubMed ID: 22776638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kidney--the body's playground for drugs: an overview of renal drug handling with selected clinical correlates.
    Perri D; Ito S; Rowsell V; Shear NH
    Can J Clin Pharmacol; 2003; 10(1):17-23. PubMed ID: 12687033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of drug transporters in the enterohepatic circulation.
    Stieger B; Meier PJ
    Pharmacogenomics; 2011 May; 12(5):611-31. PubMed ID: 21619426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo approaches to characterize transporter-mediated disposition in drug discovery.
    Feng B; Varma MV; Costales C; Zhang H; Tremaine L
    Expert Opin Drug Discov; 2014 Aug; 9(8):873-90. PubMed ID: 24857286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of drug transporter studies on drug discovery and development.
    Mizuno N; Niwa T; Yotsumoto Y; Sugiyama Y
    Pharmacol Rev; 2003 Sep; 55(3):425-61. PubMed ID: 12869659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of transporters by nuclear hormone receptors: implications during inflammation.
    Teng S; Piquette-Miller M
    Mol Pharm; 2008; 5(1):67-76. PubMed ID: 18072749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membrane transporters and drug development: relevance to pharmacogenomics, nutrigenomics, epigenetics, and systems biology.
    Yan Q
    Methods Mol Biol; 2010; 637():1-21. PubMed ID: 20419427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico strategies for modeling membrane transporter function.
    Chang C; Ray A; Swaan P
    Drug Discov Today; 2005 May; 10(9):663-71. PubMed ID: 15894231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Finding novel pharmaceuticals in the systems biology era using multiple effective drug targets, phenotypic screening and knowledge of transporters: where drug discovery went wrong and how to fix it.
    Kell DB
    FEBS J; 2013 Dec; 280(23):5957-80. PubMed ID: 23552054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines.
    Brandon EF; Bosch TM; Deenen MJ; Levink R; van der Wal E; van Meerveld JB; Bijl M; Beijnen JH; Schellens JH; Meijerman I
    Toxicol Appl Pharmacol; 2006 Feb; 211(1):1-10. PubMed ID: 15975613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Techniques: application of systems biology to absorption, distribution, metabolism, excretion and toxicity.
    Ekins S; Nikolsky Y; Nikolskaya T
    Trends Pharmacol Sci; 2005 Apr; 26(4):202-9. PubMed ID: 15808345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational approaches to modeling drug transporters.
    Chang C; Swaan PW
    Eur J Pharm Sci; 2006 Apr; 27(5):411-24. PubMed ID: 16274971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier genomics and the use of endogenous transporters to cause drug penetration into the brain.
    Pardridge WM
    Curr Opin Drug Discov Devel; 2003 Sep; 6(5):683-91. PubMed ID: 14579518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug transporters relevant to HIV therapy.
    Thomas SA
    J HIV Ther; 2004 Nov; 9(4):92-6. PubMed ID: 15731741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA transporters as drug targets for modulation of GABAergic activity.
    Schousboe A; Sarup A; Larsson OM; White HS
    Biochem Pharmacol; 2004 Oct; 68(8):1557-63. PubMed ID: 15451399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of efflux and uptake transporters in [N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine (GW572016, lapatinib) disposition and drug interactions.
    Polli JW; Humphreys JE; Harmon KA; Castellino S; O'Mara MJ; Olson KL; John-Williams LS; Koch KM; Serabjit-Singh CJ
    Drug Metab Dispos; 2008 Apr; 36(4):695-701. PubMed ID: 18216274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transporter-mediated drug-drug interactions.
    Zhang L; Huang SM; Lesko LJ
    Clin Pharmacol Ther; 2011 Apr; 89(4):481-4. PubMed ID: 21423238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetics/genomics of membrane transporters in cancer chemotherapy.
    Huang Y
    Cancer Metastasis Rev; 2007 Mar; 26(1):183-201. PubMed ID: 17323126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.